160 related articles for article (PubMed ID: 28755322)
1. Extraneuraxial metastases in medulloblastoma: is histology and molecular biology important?
Gupta T; Dasgupta A; Epari S; Shirsat N; Chinnaswamy G; Jalali R
J Neurooncol; 2017 Nov; 135(2):419-421. PubMed ID: 28755322
[No Abstract] [Full Text] [Related]
2. [Medulloblastoma in adults].
Hopf-Jensen S; Buchalla R; Preiß M; Feist H; Börm W; Müller-Hülsbeck S
Rofo; 2014 Sep; 186(9):825-8. PubMed ID: 25171381
[No Abstract] [Full Text] [Related]
3. [Medulloblastoma in adults: report of 13 cases and literature review].
Drissi J; Affane M; Elomrani A; Khouchani M
Pan Afr Med J; 2015; 22():126. PubMed ID: 26889307
[TBL] [Abstract][Full Text] [Related]
4. Panventricular medulloblastoma.
Bhatoe HS; Dutta V; Chaturvedi A
J Neurooncol; 2005 Sep; 74(3):281-2. PubMed ID: 16187024
[No Abstract] [Full Text] [Related]
5. Medulloblastoma: recent advances and directions in diagnosis and management--Part I.
Chin HW; Maruyama Y; Young AB
Curr Probl Cancer; 1984 May; 8(11):4-54. PubMed ID: 6383718
[No Abstract] [Full Text] [Related]
6. Rethinking medulloblastoma from a targeted therapeutics perspective.
Hashimoto Y; Penas-Prado M; Zhou S; Wei J; Khatua S; Hodges TR; Sanai N; Xiu J; Gatalica Z; Kim L; Kesari S; Rao G; Spetzler D; Heimberger A
J Neurooncol; 2018 Sep; 139(3):713-720. PubMed ID: 29869738
[TBL] [Abstract][Full Text] [Related]
7. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
[TBL] [Abstract][Full Text] [Related]
8. Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma.
Monje M; Beachy PA; Fisher PG
J Clin Oncol; 2011 Apr; 29(11):1395-8. PubMed ID: 21357776
[No Abstract] [Full Text] [Related]
9. Risk-adapted chemotherapy in childhood medulloblastoma.
Varan A
Expert Rev Anticancer Ther; 2011 May; 11(5):771-80. PubMed ID: 21554052
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma: tumor biological and clinical perspectives.
Friedman HS; Oakes WJ; Bigner SH; Wikstrand CJ; Bigner DD
J Neurooncol; 1991 Aug; 11(1):1-15. PubMed ID: 1919642
[TBL] [Abstract][Full Text] [Related]
11. [Medulloblastoma].
Choux M; Lena G; Alfonsi S; Bernard JL; Clément R; Elbaze F; Gambarelli D; Hassoun J; Lerpinière JP; Lucas C; Pinsard N; Raybaud C; Raybaud C; Rigaud F; Ruffo M; Tapounie E
Neurochirurgie; 1982; 28 Suppl 1():1-229. PubMed ID: 7110502
[No Abstract] [Full Text] [Related]
12. MRI surrogates for molecular subgroups of medulloblastoma.
Perreault S; Ramaswamy V; Achrol AS; Chao K; Liu TT; Shih D; Remke M; Schubert S; Bouffet E; Fisher PG; Partap S; Vogel H; Taylor MD; Cho YJ; Yeom KW
AJNR Am J Neuroradiol; 2014 Jul; 35(7):1263-9. PubMed ID: 24831600
[TBL] [Abstract][Full Text] [Related]
13. WNT-activated Pediatric Medulloblastoma Associated With Metastasis to the Suprasellar Region and Hypopituitarism.
Ahmad N; Eltawel M; Kashgari A; Alassiri AH
J Pediatr Hematol Oncol; 2021 May; 43(4):e512-e516. PubMed ID: 32815879
[TBL] [Abstract][Full Text] [Related]
14. Molecular studies in pediatric medulloblastomas.
Ramachandran C; Khatib Z; Escalon E; Fonseca HB; Jhabvala P; Medina LS; D'Souza B; Ragheb J; Morrison G; Melnick SJ
Brain Tumor Pathol; 2002; 19(1):15-22. PubMed ID: 12455884
[TBL] [Abstract][Full Text] [Related]
15. Second cancers after medulloblastoma: population-based results from the United States and Sweden.
Goldstein AM; Yuen J; Tucker MA
Cancer Causes Control; 1997 Nov; 8(6):865-71. PubMed ID: 9427429
[TBL] [Abstract][Full Text] [Related]
16. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
17. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.
Iorgulescu JB; Van Ziffle J; Stevers M; Grenert JP; Bastian BC; Chavez L; Stichel D; Buchhalter I; Samuel D; Nicolaides T; Banerjee A; Mueller S; Gupta N; Tihan T; Bollen AW; Northcott PA; Kool M; Pfister S; Korshunov A; Perry A; Solomon DA
Acta Neuropathol; 2018 Apr; 135(4):635-638. PubMed ID: 29435664
[No Abstract] [Full Text] [Related]
18. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
[TBL] [Abstract][Full Text] [Related]
19. Shedding light on adult medulloblastoma: current management and opportunities for advances.
Brandes AA; Franceschi E
Am Soc Clin Oncol Educ Book; 2014; ():e82-7. PubMed ID: 24857151
[TBL] [Abstract][Full Text] [Related]
20. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
